Literature DB >> 2571348

Appearance of predictors of disease progression in relation to the development of AIDS.

F de Wolf1, J M Lange, J T Houweling, J W Mulder, J Beemster, P T Schellekens, R A Coutinho, J van der Noordaa, J Goudsmit.   

Abstract

To study the natural history of HIV-1 infection in relation to serological and immunological profiles, 199 asymptomatic HIV-1-antibody (HIV-1-core-antibody)-seropositive and 76 seroconverted homosexual men were followed prospectively for 39 months. AIDS was diagnosed in 38 men. The AIDS attack rate was 20.8% after 39 months. The AIDS attack rate in the HIV-I-core-antibody positives was 12.1, versus 30.1% in the HIV-1-core-antibody negatives (P less than 0.001), and it was 13.3% in the HIV-1-antigen (HIV-1-Ag) negatives versus 53.9% in the HIV-1-Ag positives (P less than 0.001). The AIDS attack rate after 39 months was 10.9% in men with counts greater than or equal to 0.5 x 10(9)/l and 49.9% in those with CD4+ lymphocyte counts less than 0.5 x 10(9)/l. AIDS attack rates after 30 months in the same cohort have been previously reported [1], and were as follows: 6.8% in the core-antibody positives versus 35.7% in the core-antibody negatives. 6.9% in the HIV-1-Ag negatives versus 43.9% in the HIV-1-Ag positives, and 6.1% in those with CD4+ lymphocyte counts greater than or equal to 0.5 versus 51.9% in those with CD4+ lymphocyte counts less than 0.5 x 10(9)/l. The disappearance of core antibody, the appearance of antigen and the occurrence of low CD4+ lymphocyte counts preceded AIDS by a mean (s.d.) of 21.3 (8.9), 17.7 (8.8) and 15.7 (8.9) months, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571348     DOI: 10.1097/00002030-198909000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

2.  Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.

Authors:  J W Mulder; P Krijnen; R A Coutinho; M Bakker; J Goudsmit; J M Lange
Journal:  Genitourin Med       Date:  1991-06

Review 3.  Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection.

Authors:  A G Bird
Journal:  Genitourin Med       Date:  1990-06

4.  HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

Authors:  J W Mulder; P Krijnen; J Goudsmit; J K Schattenkerk; P Reiss; J M Lange
Journal:  Genitourin Med       Date:  1990-06

Review 5.  Recent advances in the medical management of early HIV disease.

Authors:  P A Volberding
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

6.  Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection.

Authors:  R Enzensberger; W Braun; C July; E B Helm; H W Doerr
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

7.  Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection.

Authors:  T Cabezas; E Quirós; F Garcia; J Hernández-Quero; M C Bernal; M A Martinez; J de la Higuera; G Piédrola; M C Maroto
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

8.  Using CD4 counts to evaluate the stages and epidemiology of HIV infection in South Carolina public clinic patients.

Authors:  S Luby; J Jones; J Horan
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

9.  The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.

Authors:  Jaap Goudsmit
Journal:  Eur J Epidemiol       Date:  2016-03-26       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.